Safety of 15-deoxyspergualin in the treatment of glomerulonephritis associated with active systemic lupus erythematosus

Full Text

The Full Text of this article is available as a PDF (67.2 KB).

Figure 1.

 Proteinuria during 15-DSG treatment in patients 1–3. 24 hour urine was collected at the day of entry into the study or the last days of the cycles as indicated. Owing to menstrual bleeding urine collection was not possible in patient 1 at the end of cycle 4 and in patient 2 at the end of cycles 4, 6, and 7.